**RFK Jr. remains HHS Secretary with strong backing from President Trump, supporting trader views that he will likely stay in the role through December 31, 2026.** As of early September 2026, he continues implementing “Make America Healthy Again” priorities, including vaccine schedule revisions, agency reorganizations, leadership changes at HHS components, and staffing shifts that have increased political appointees. Recent coverage marking his one-year anniversary in the post highlights ongoing policy activity and White House alignment, with Trump publicly endorsing him and no reported moves toward removal or resignation. Internal agency tensions and external criticism exist, but these have not produced verifiable developments that would shift the implied probability away from continuation. The market reflects consensus on sustained tenure absent major new catalysts before year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено$24,323 Обс.
$24,323 Обс.
$24,323 Обс.
$24,323 Обс.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Ринок відкрито: Mar 19, 2026, 2:02 PM ET
Вирішувач
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Вирішувач
0x65070BE91...**RFK Jr. remains HHS Secretary with strong backing from President Trump, supporting trader views that he will likely stay in the role through December 31, 2026.** As of early September 2026, he continues implementing “Make America Healthy Again” priorities, including vaccine schedule revisions, agency reorganizations, leadership changes at HHS components, and staffing shifts that have increased political appointees. Recent coverage marking his one-year anniversary in the post highlights ongoing policy activity and White House alignment, with Trump publicly endorsing him and no reported moves toward removal or resignation. Internal agency tensions and external criticism exist, but these have not produced verifiable developments that would shift the implied probability away from continuation. The market reflects consensus on sustained tenure absent major new catalysts before year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено


Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання